Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05599022 · ClinicalTrials.gov registry record · NA

Randomized Assessment of TcMS for VT Storm

A NA study of Ventricular Tachycardia, sponsored by University of Pennsylvania.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05599022 is a NA study of Ventricular Tachycardia that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 60 participants, below the 287-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05599022, a NA study of Ventricular Tachycardia, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Three-arm randomized clinical trial comparing two strategies of TcMS to sham stimulation in patients with VT storm. The hypothesis of the study is that TcMS will reduce the burden of VT in the 24 hours after randomization compared to sham stimulation and that TcMS with theta burst stimulation (TBS) will be more effective at reducing VT burden than low frequency TcMS.

Conditions Studied

Interventions

  • DEVICE Magnetic Stimulation

Study Locations (1)

Pennsylvania

  • Hospital of the University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-05-22
Est. Completion 2028-09
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT05599022

The ClinicalTrials.gov registry entry for NCT05599022 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 287-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (79% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Stimulation is the first listed.

NCT05599022 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05599022 about?

NCT05599022 is a clinical study titled "Randomized Assessment of TcMS for VT Storm". Three-arm randomized clinical trial comparing two strategies of TcMS to sham stimulation in patients with VT storm. The hypothesis of the study is that TcMS will reduce the burden of VT in the 24 hours after randomization compared to sham stimulation and that TcMS with theta burst stimulation (TBS) ...

What is the current status of trial NCT05599022?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-05-22. Estimated completion is 2028-09.

What conditions does trial NCT05599022 study?

This clinical trial studies the following conditions: Ventricular Tachycardia.

What interventions are being tested in trial NCT05599022?

The interventions under investigation include: Magnetic Stimulation (DEVICE).

Who is sponsoring clinical trial NCT05599022?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05599022 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ventricular Tachycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.